Prentiss Smith & Co’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-3,582
| Closed | -$490K | – | 278 |
|
|
2018
Q2 | $490K | Sell |
3,582
-38,787
| -92% | -$3.52M | 0.3% | 45 |
|
|
2018
Q1 | $3.34M | Buy |
42,369
+41,619
| +5,549% | +$3.07M | 1.75% | 21 |
|
|
2017
Q4 | $51K | Buy |
750
+250
| +50% | +$13K | 0.02% | 130 |
|
|
2017
Q3 | $20K | Hold |
500
| – | – | 0.01% | 164 |
|
|
2017
Q2 | $20K | Buy |
+500
| New | +$18.3K | 0.01% | 169 |
|
|
2017
Q1 | – | Sell |
-1,000
| Closed | -$18K | – | 278 |
|
|
2016
Q4 | $18K | Hold |
1,000
| – | – | 0.01% | 171 |
|
|
2016
Q3 | $23K | Hold |
1,000
| – | – | 0.01% | 164 |
|
|
2016
Q2 | $19K | Hold |
1,000
| – | – | 0.01% | 174 |
|
|
2016
Q1 | $18K | Hold |
1,000
| – | – | 0.01% | 192 |
|
|
2015
Q4 | $21K | Hold |
1,000
| – | – | 0.01% | 187 |
|
|
2015
Q3 | $18K | Buy |
+1,000
| New | +$25K | 0.01% | 181 |
|
|
2015
Q1 | – | Sell |
-1,973
| Closed | -$44K | – | 334 |
|
|
2014
Q4 | $44K | Sell |
1,973
-95,199
| -98% | -$2.2M | 0.02% | 154 |
|
|
2014
Q3 | $1.84M | Sell |
97,172
-3,072
| -3% | -$73.3K | 0.92% | 28 |
|
|
2014
Q2 | $2.7M | Sell |
100,244
-1,417
| -1% | -$35.9K | 1.37% | 22 |
|
|
2014
Q1 | $3.29M | Sell |
101,661
-1,441
| -1% | -$46.8K | 1.75% | 19 |
|
|
2013
Q4 | $2.46M | Buy |
+103,102
| New | +$2.88M | 1.29% | 20 |
|
Prentiss Smith & Co's FMI Position: Q3 2018 in Review
Prentiss Smith & Co sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 3,582 shares — an estimated $490K sold.
Prentiss Smith & Co first reported a position in FMI in Q4 2013 and held it in 16 quarters. The position peaked at $3.34M in Q1 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Prentiss Smith & Co reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Prentiss Smith & Co sold 3,582 Foundation Medicine, Inc. shares in Q3 2018, an estimated $490K.
- Prentiss Smith & Co first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 16 quarters.
- Prentiss Smith & Co's Foundation Medicine, Inc. position peaked at $3.34M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Prentiss Smith & Co's 13F filing for Q3 2018, filed 23 Oct 2018.